Ignite Creation Date:
2025-12-24 @ 2:10 PM
Ignite Modification Date:
2025-12-29 @ 8:47 PM
Study NCT ID:
NCT00044395
Status:
COMPLETED
Last Update Posted:
2007-11-06
First Post:
2002-08-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
Sponsor:
Eli Lilly and Company
Organization:
Study Overview
Official Title:
LY333531 Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status:
COMPLETED
Status Verified Date:
2007-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this protocol is to determine if an investigational drug is effective in treating nerve malfunction in diabetes.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| B7A-MC-MBBP | None | None | View |